Jason V. Coloma, CEO: Maze Therapeutics MAZE Sell · Filed 05/27

Trade details

Type: Insider sale
Amount: $665,643.64
Shares · price: 25,582 sh · $26.02 a share
Held after: 350,987 sh
Stock: Maze Therapeutics MAZE
Person: Jason V. ColomaCEO
Trade date: 26/05/26
Filed: 26/05/27
Days to filing: 1 days

Sold 6.8% of holdings

Share of holding sold: 6.8%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 04/26~06/25

Jason V. Coloma's recent trades

Jason V. ColomaCEO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$862.2K
31,908 sh
$862.2K
Filed 10/02
Traded 10/01
Jason V. ColomaCEO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$70.1K
2,593 sh
$70.1K
Filed 10/02
Traded 10/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$933.3K
34,501 sh
$933.3K
Filed 10/01
Traded 10/01
Jason V. ColomaCEO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$623.4K
23,497 sh
$623.4K
Filed 09/02
Traded 09/02
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$908.1K
34,501 sh
$908.1K
Filed 09/01
Traded 09/01

Jason V. Coloma, CEO — sold $665.6K of Maze Therapeutics MAZE · 6.8% of holdings · 10b5-1 plan | Whalegun